Sign in
CompletedNo phase

Promoting Alcohol Treatment Engagement Post-hospitalization

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Status
Completed
People taking part
417 people enrolled
Started
13 Sept 2022
Ended
31 Aug 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Brief Negotiated Interview (BNI)
  • BNI+facilitated provision of MAUD
  • Brief Negotiated Interview BNI+facilitated provision of MAUD+CBT4CBT
Record updated
8 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • hospitalized at Yale New Haven Hospital (YNHH)
  • meet Diagnostic and Statistical Manual (DSM-5) criteria for a moderate to severe AUD (regardless of primary reason for hospitalization) consistent with clinical guidelines for MAUD initiation
  • >1 heavy drinking day by TLFB in 30 days prior to hospitalization
  • willing to consider MAUD
  • willing and able to be contacted for follow-up
  • provide written informed consent

Who cannot take part

  • meet DSM-5 criteria for untreated moderate to severe opioid use disorder
  • life-threatening or unstable medical, surgical, or psychiatric condition that prohibits study participation
  • have been engaged in formal AUD treatment in the past 30 days (i.e., excluding mutual help groups, such as Alcoholics Anonymous)
  • self-reported or urine testing confirming pregnancy, nursing, or trying to conceive
  • inability to provide >1 collateral contact for a friend or family member
  • anticipate being unable to return for follow-up assessments for any reason, such as travel, incarceration, planned procedure
  • inability to understand English or Spanish

Where in United States

  • Yale New Haven HospitalNew Haven, United States

About the trial

What the trial wants to find out

This study is a 3-arm randomized clinical trial to evaluate the effectiveness of hospital-initiated Alcohol Use Disorder treatment, involving a Brief Negotiated Interview (with referral and telephone booster) alone, BNI+facilitated provision of MAUD, BNI+facilitated provision of MAUD+CBT4CBT on AUD treatment engagement, alcohol use and healthcare utilization.

The 3 groups in the trial

  • Brief Negotiated Interview (with referral and telephone booster) aloneOther group

    All participants will receive BNI with referral and a 15-20 minute telephone booster delivered by a trained Health Promotion Advocate (HPA) at 2 weeks. The purpose of the BNI is to assist patients in recognizing and changing levels of alcohol consumption that pose health risks. The main goals of the BNI are to: 1) lessen ambivalence about reducing alcohol use; and 2) negotiate strategies for change. During BNI, the HPA will: 1) Raise the subject of alcohol; 2) Provide feedback: review the patient's alcohol consumption, make a connection to the patient's medical condition and reason for hospitalization; review guidelines for lower risk alcohol use; 3) Enhance motivation: have the patient identify on a readiness change ruler and develop discrepancy; and 4) Negotiate and Advise: negotiate goal, give advice, have patient complete drinking agreement; summarize and arrange follow-up.

    Treatment: Brief Negotiated Interview (BNI)

  • BNI+MAUDExisting treatment, for comparison

    For either BNI+facilitated provision of MAUD or BNI+facilitated provision of MAUD+CBT4CBT, the HPA will provide education and counseling regarding MAUD as part of the BNI to the participant and communicate to the primary medical team that MAUD is indicated. The specific MAUD chosen will be made at the discretion of the patient and the primary medical team with recommendations from the study physicians, with a goal of prioritizing FDA approved medications. Participants will be encouraged to initiate (or receive as in the case of injectable naltrexone) MAUD prior to discharge and will be provided a prescription for a 30-day supply. Medications will be obtained through regular means and not provided directly through the study. During the BNI telephone booster, the HPA will inquire about and address any barriers to MAUD and encourage continued adherence.

    Treatment: BNI+facilitated provision of MAUD

  • BNI+MAUD+CBT4CBTTreatment being tested

    Participants randomized to BNI+facilitated provision of MAUD+CBT4CBT will be given a username and password to access the web-based program and be encouraged to begin accessing the program during their hospitalization. The HPA will assist each participant with login during the first session and be available to answer any questions. Participants will be asked to complete no more than two modules per week, with an expectation of completing all seven modules by the end of the 34-day post-discharge. The program tracks, for each participant, time logged onto the program, modules accessed, progress through the program from session to session, completion of homework assignments, and learning of CBT principles through brief quizzes. Participants will be allowed to repeat modules as desired. During the BNI telephone booster, the HPA will inquire about engagement with CBT4CBT, address any questions and problems with the program, and encourage practice of coping activities (i.e., homework).

    Treatment: Brief Negotiated Interview BNI+facilitated provision of MAUD+CBT4CBT

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Promoting Alcohol Treatment Engagement Post-hospitalization With Brief Intervention, Medications and CBT4CBT: A Randomized Clinical Trial in a Diverse Patient Population.
Publications
Record updated
8 September 2026